ABVC BioPharma Inc. (ABVC) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ABVC BioPharma Inc.

    NASDAQ: ABVC · Real-Time Price · USD
    2.65
    -0.18 (-6.36%)
    At close: Sep 02, 2025, 1:10 PM

    ABVC BioPharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -5.26M -10.52M -16.31M -12.04M
    Depreciation & Amortization
    		 200.92K 28.53K 23.8K 11.99K
    Stock-Based Compensation
    		 n/a 1.64M 7.04M 5.31M
    Other Working Capital
    		 -114.46K 402.53K 1.22M -1.44M
    Other Non-Cash Items
    		 3.66M 4.01M 353.04K -91.05K
    Deferred Income Tax
    		 n/a 115.67K 864.8K 824.2K
    Change in Working Capital
    		 -408.42K 490.77K 635.57K -1.61M
    Operating Cash Flow
    		 -1.81M -4.24M -7.4M -7.6M
    Capital Expenditures
    		 n/a -21.2K -119.69K -17.5K
    Cash Acquisitions
    		 n/a -338.99K -1.6M -680.92K
    Purchase of Investments
    		 n/a n/a -1.6M -107.55K
    Sales Maturities Of Investments
    		 n/a n/a 3.2M 788.46K
    Other Investing Acitivies
    		 n/a n/a -1.6M -788.46K
    Investing Cash Flow
    		 n/a -360.19K -1.72M -805.97K
    Debt Repayment
    		 15.93K 462.62K 350K -590.83K
    Common Stock Repurchased
    		 -7.32K n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 1.94M 2.41M n/a -533.07K
    Financial Cash Flow
    		 1.98M 3.92M 4.01M 10M
    Net Cash Flow
    		 147.03K -674.95K -5.17M 1.56M
    Free Cash Flow
    		 -1.81M -4.26M -7.52M -7.62M

    Add to Watchlist